abstract |
Antibodies to human N3pGlu A, compositions containing such antibodies to N3pGlu A, and methods of using such antibodies to N3pGlu A for the treatment of disease characterized by A deposition, including clinical or preclinical Alzheimer's disease, Down's syndrome, and clinical or preclinical cerebral amyloid angiopathy. |